Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Gout Epidemiology in Chronic Kidney Disease: Transition to End-stage Kidney Disease and Impact of Renal Transplant

Award Number: R01AR085886
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/10/2025
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

Gout Epidemiology in Chronic Kidney Disease: Transition to End-stage Kidney Disease and Impact of Renal Transplant - PROJECT SUMMARY Gout coexisting with advanced chronic kidney disease (CKD) poses a complex and under-researched medical challenge. There is scant evidence and an important knowledge gap to guide gout management in patients transitioning from advanced CKD to end-stage kidney disease (ESKD), where dialysis or kidney transplantation (KT) becomes necessary. Understanding the burden of gout during the transition from non- dialysis CKD to ESKD and subsequently to KT is essential for optimizing treatment strategies and improving patient outcomes. This research, utilizing data from the United States Renal Data System (USRDS), aims to explore the evolution of gout burden (including flares and healthcare utilization) from advanced CKD to ESKD, and for those undergoing KT. Our overarching goal is to test the central hypothesis that individuals with concomitant gout and CKD progressing to dialysis (ESKD) will have an increased burden of gout (flares, emergency room visits, hospitalization, and cardiovascular disease) during the period of transition into dialysis. In addition, gout burden after kidney transplantation has decreased after the transition of anti-rejection regiments to those not using cyclosporine (primarily) and calcineurin inhibitors in general. We will test this hypothesis using data from the United States Renal Data System (USRDS) and the United Network for Organ Sharing (UNOS). For this, we will apply a self-controlled case series (SCCS) method, where individuals act as their own controls, reducing the influence of between-person confounding variables. We will also conduct a retrospective cohort study examining the change in the incidence of gout, immunosuppressive regimes, and related patient outcomes in Kidney Transplantation. The two aims will rigorously evaluate the natural history of the gout burden in critical phases of CKD and ESKD . The goal of Aim 1 (CKD to ESKD aim) examine the trajectory of gout burden and treatment patterns as patients transition from advanced CKD to ESKD. The goal of Aim 2 (Kidney transplantation aim) is to assess changes in gout incidence, gout flares, and outcomes including cardiovascular hospitalizations and mortality among KT recipients.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $186,134 )
2026	2026	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	6/12/2026	NON-COMPETING CONTINUATION	$186,134
														Subtotal = $186,134

Issue Date FY: 2025 ( Subtotal = $240,715 )
2025	2025	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	7/10/2025	NEW	$240,715
														Subtotal = $240,715

Grand Total All Awards = $426,849

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Gout Epidemiology in Chronic Kidney Disease: Transition to End-stage Kidney Disease and Impact of Renal Transplant

Award Number: R01AR085886

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/10/2025

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer